Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD147 regulates antitumor CD8+ T-cell responses to facilitate tumor-immune escape
Yatong Chen, Jing Xu, Xiaodong Wu, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 8, pp. 1995-2009
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer
Zhenchuan Liu, Tingting Wang, Yunlang She, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 258
CD8+ T cell-based cancer immunotherapy
Yanxia Chen, Dingning Yu, Hui Qian, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 21
Dysfunction of exhausted T cells is enforced by MCT11-mediated lactate metabolism
Ronal Peralta, Bingxian Xie, Konstantinos Lontos, et al.
Nature Immunology (2024) Vol. 25, Iss. 12, pp. 2297-2307
Open Access | Times Cited: 19
SARS-CoV-2 pseudovirus enters the host cells through spike protein-CD147 in an Arf6-dependent manner
Yun-Qi Zhou, Ke Wang, Xueyan Wang, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 1135-1144
Open Access | Times Cited: 34
CXCL9-modified CAR T cells improve immune cell infiltration and antitumor efficacy
Yonggui Tian, Chunli Wen, Zhen Zhang, et al.
Cancer Immunology Immunotherapy (2022) Vol. 71, Iss. 11, pp. 2663-2675
Open Access | Times Cited: 32
Role of CD147 in the development and diagnosis of hepatocellular carcinoma
Defa Huang, Dingyu Rao, Qing Jin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
The functions and regulatory pathways of S100A8/A9 and its receptors in cancers
Huimin Zhou, Cong Zhao, Rong‐Guang Shao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
CD147: an integral and potential molecule to abrogate hallmarks of cancer
Alphonce M. K. Nyalali, Angela U. Leonard, Yongxiang Xu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 19
Alarmin S100A8 imparts chemoresistance of esophageal cancer by reprogramming cancer-associated fibroblasts
Xinjie Chen, Guoyu Cheng, Liang Zhu, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 6, pp. 101576-101576
Open Access | Times Cited: 6
The tumor microenvironment shapes the molecular characteristics of exhausted CD8+ T cells
Hongcheng Cheng, Kaili Ma, Lianjun Zhang, et al.
Cancer Letters (2021) Vol. 506, pp. 55-66
Closed Access | Times Cited: 33
Hypoxia‐activated ADCC‐enhanced humanized anti‐CD147 antibody for liver cancer imaging and targeted therapy with improved selectivity
Fangzheng Qi, Huishan Su, Bo Wang, et al.
MedComm (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 4
KRAS mutation promotes immune escape of lung adenocarcinoma via ZNF24/SLC7A5/PD-L1 axis
Leilei Li, Qiang Feng, Ya Jiang, et al.
Research Square (Research Square) (2025)
Closed Access
SERPINE1 Facilitates Metastasis in Gastric Cancer Through Anoikis Resistance and Tumor Microenvironment Remodeling
Bofang Wang, Baohong Gu, Lei Gao, et al.
Small (2025)
Closed Access
SPATIAL ANALYSIS IDENTIFIES CD147 AS A NOVEL MARKER OF HIGH-GRADE CHILDHOOD POSTERIOR FOSSA EPENDYMOMA
Donatella Lucchetti, Filomena Colella, Antonio d’Amati, et al.
Laboratory Investigation (2025), pp. 104175-104175
Closed Access
Mechanism Study of E2F8 Activation of SPC25‐Mediated Glutamine Metabolism Promoting Immune Escape in Lung Adenocarcinoma
Machang Luo, Lingyan Xie, Benjamin Lin, et al.
Immunology (2025)
Closed Access
An immune escape-related gene signature for predicting the prognostic and immune microenvironment in osteosarcoma
Meng Chen, Chuan Li, Yongqing Xu
Archives of Medical Science (2025)
Open Access
A Brief look at antitumor effects of doxycycline in the treatment of colorectal cancer and combination therapies
Kimia Ghasemi, Kosar Ghasemi
European Journal of Pharmacology (2021) Vol. 916, pp. 174593-174593
Closed Access | Times Cited: 19
A Large-Scale Exome-Wide Association Study Identifies Novel Germline Mutations in Lung Cancer
Sipeng Shen, Zaiming Li, Yunke Jiang, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 208, Iss. 3, pp. 280-289
Open Access | Times Cited: 7
High CD8+tumor-infiltrating lymphocytes indicate severe exhaustion and poor prognosis in angioimmunoblastic T-cell lymphoma
Qiqi Zhu, Yiming Yang, Xueqin Deng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Sphingosine kinase 1 promotes tumor immune evasion by regulating the MTA3-PD-L1 axis
Poyee Lau, Guanxiong Zhang, Shuang Zhao, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 10, pp. 1153-1167
Open Access | Times Cited: 12
Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2
Jiewen Fu, Binghui Song, Jiaman Du, et al.
Molecular Biology Reports (2022) Vol. 50, Iss. 3, pp. 2269-2281
Open Access | Times Cited: 12
Establishing the role of BRCA1 in the diagnosis, prognosis and immune infiltrates of breast invasive cancer by bioinformatics analysis and experimental validation
Leilei Li, Shuangyan Li, Xuyang Zhang, et al.
Aging (2024)
Open Access | Times Cited: 2
A Trefoil factor 3-Lingo2 axis restrains proliferative expansion of type-1 T helper cells during GI nematode infection
Lucas Ethgen, Christopher Pastore, Cailu Lin, et al.
Mucosal Immunology (2024) Vol. 17, Iss. 2, pp. 238-256
Open Access | Times Cited: 2
Immunometabolic Markers in a Small Patient Cohort Undergoing Immunotherapy
Joshua Hofbauer, Andreas Hauck, Carina Matos, et al.
Biomolecules (2022) Vol. 12, Iss. 5, pp. 716-716
Open Access | Times Cited: 8
Bioactivity-Driven Synthesis of the Marine Natural Product Naamidine J and Its Derivatives as Potential Tumor Immunological Agents by Inhibiting Programmed Death-Ligand 1
Pan-Pan Fu, Qun Wang, Qing Zhang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 8, pp. 5427-5438
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top